Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary. J Oncol Pract. 2016 Feb; 12(2):180-1.

View in: PubMed

subject areas

Antibodies, Monoclonal
Antineoplastic Agents
Colorectal Neoplasms
DNA Mutational Analysis
ErbB Receptors
Genes, ras
Genetic Testing
Humans
Mutation
Prognosis

authors with profiles

Richard Schilsky